Unknown

Dataset Information

0

G-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth.


ABSTRACT: Hypoxia-inducible factor-1 (HIF-1) plays crucial roles in tumor promotion by upregulating its target genes, which are involved in energy metabolism, angiogenesis, cell survival, invasion, metastasis, and drug resistance. The HIF-1alpha subunit, which is regulated by O2-dependent hydroxylation, ubiquitination, and degradation, has been identified as an important molecular target for cancer therapy. We have rationally designed G-rich oligodeoxynucleotides (ODNs) as inhibitors of HIF-1alpha for human cancer therapy. The lead compounds, JG243 and JG244, which form an intramolecular parallel G-quartet structure, selectively target HIF-1alpha and decreased levels of both HIF-1alpha and HIF-2alpha (IC50 < 2 micromol/l) and also inhibited the expression of HIF-1-regulated proteins [vascular endothelial growth factor (VEGF), Bcl-2, and Bcl-XL], but did not disrupt the expression of p300, Stat3, or p53. JG-ODNs induced proteasomal degradation of HIF-1alpha and HIF-2alpha that was dependent on the hydroxylase activity of prolyl-4-hydroxylase-2. JG243 and JG244 dramatically suppressed the growth of prostate, breast, and pancreatic tumor xenografts. Western blots from tumor tissues showed that JG-ODNs significantly decreased HIF-1alpha and HIF-2alpha levels and blocked the expression of VEGF. The JG-ODNs are novel anticancer agents that suppress tumor growth by inhibiting HIF-1.

SUBMITTER: Guan Y 

PROVIDER: S-EPMC2839212 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

G-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth.

Guan Yongli Y   Reddy Kavitha Ramasamy KR   Zhu Qiqing Q   Li Yifei Y   Lee KangAe K   Weerasinghe Priya P   Prchal Josef J   Semenza Gregg L GL   Jing Naijie N  

Molecular therapy : the journal of the American Society of Gene Therapy 20090915 1


Hypoxia-inducible factor-1 (HIF-1) plays crucial roles in tumor promotion by upregulating its target genes, which are involved in energy metabolism, angiogenesis, cell survival, invasion, metastasis, and drug resistance. The HIF-1alpha subunit, which is regulated by O2-dependent hydroxylation, ubiquitination, and degradation, has been identified as an important molecular target for cancer therapy. We have rationally designed G-rich oligodeoxynucleotides (ODNs) as inhibitors of HIF-1alpha for hum  ...[more]

Similar Datasets

| S-EPMC2604945 | biostudies-literature
| S-EPMC2673882 | biostudies-literature
| S-EPMC309606 | biostudies-literature
| S-EPMC2885428 | biostudies-literature
| S-EPMC1618093 | biostudies-literature
2013-11-05 | GSE43108 | GEO
| S-EPMC1850121 | biostudies-literature
| S-EPMC2823506 | biostudies-literature
| S-EPMC2043574 | biostudies-literature
2013-11-05 | E-GEOD-43108 | biostudies-arrayexpress